Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibody.
Pacchiana G, Chiriaco C, Stella MC, Petronzelli F, De Santis R, Galluzzo M, Carminati P, Comoglio PM, Michieli P, Vigna E.
Pacchiana G, et al. Among authors: comoglio pm.
J Biol Chem. 2010 Nov 12;285(46):36149-57. doi: 10.1074/jbc.M110.134031. Epub 2010 Sep 10.
J Biol Chem. 2010.
PMID: 20833723
Free PMC article.